Key result
Synthetic low-molecular weight thrombin inhibitors show promise as targeted antithrombotic therapies.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
(1995). Synthetic Low-Molecular Weight Thrombin Inhibitors: The Ideal Antithrombotic Drug? an Introduction. Journal of Enzyme Inhibition: Vol. 9, No. 1, pp. 1-2.
No takes yet. Share an insight, caveat, or question.
Stürzebecher et al. (1995) studied this question. Synthetic low-molecular weight thrombin inhibitors are evaluated for their potential as ideal antithrombotic drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: